CN106110243A - A kind of Chinese medicine composition with analgesic activity - Google Patents
A kind of Chinese medicine composition with analgesic activity Download PDFInfo
- Publication number
- CN106110243A CN106110243A CN201610522223.3A CN201610522223A CN106110243A CN 106110243 A CN106110243 A CN 106110243A CN 201610522223 A CN201610522223 A CN 201610522223A CN 106110243 A CN106110243 A CN 106110243A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- composition
- present
- medicine composition
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/20—Aceraceae (Maple family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
Abstract
The present invention disclose a kind of have pain and the Chinese medicine composition of bone strengthening.Said composition is made up of 33 taste crude drug such as Radix Notoginseng, Rhizoma Bergeniae scopulosae, Cortex Ampelopsis Aconitifoliae Radicis, Scorpio, Squama Manis, acer yangjuechi, Rhizoma Panacis Japonici, Daphne giraldii Nitsche, Radix Lamiophlomidis Rotatae, Semen Strychni.Chinese medicine composition of the present invention adds customary adjuvant according to common process and makes emplastrum, ointment, spray, liniment or the tincture of clinical acceptance.Pharmaceutical composition of the present invention is that pure Chinese medicine is made, and has stronger analgesic activity, and analgesic effect is notable, and no dependence has no side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of Chinese medicine composition with analgesic activity.
Background technology
Pain is a kind of protection mechanism of body self, and it both can make body avoid some may damage the danger of body
Stimulate, it is also possible to be a kind of alarm of body abnormality.But meanwhile, pain is likely to damage body, it
Existence can cause the change of psychology and emotion-directed behavior, becomes a kind of pernicious stimulation, causes autonomic nervous system and hormonal system
The change of function, thus the rising of increased heart rate, blood pressure, perspiration, hypermyotonia, blood system change, endocrine occur and exempts from
The phenomenons such as epidemic disease system disorders, have had a strong impact on the life of people.At present, clinical conventional analgesic is broadly divided into three classes: non-steroid
Body anti-inflammation analgesia medicine, central analgesics and narcosis analgesic.NSAID (non-steroidal anti-inflammatory drug) is a class medicine of wide clinical application,
But gastrointestinal tract and cardiovascular adverse effects limit its application;Central analgesics and narcosis analgesic effect are efficient, are used for
Moderate and severe pain, long-term taking may result in the most serious untoward reaction, and produces toleration;Except above-mentioned three class analgesic
Outward, the most some other analgesic, but analgesic activity is unsatisfactory.Therefore, it is badly in need of developing a kind of new potent, safe, resistance to
Good, the medicine of no dependence by property.
Summary of the invention
Present invention aim at providing a kind of Chinese medicine composition with analgesic activity.
The present invention is achieved through the following technical solutions:
The crude drug of Chinese medicine composition of the present invention consists of:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
The crude drug composition of Chinese medicine composition of the present invention is preferably:
Chinese medicine composition of the present invention according to common process add customary adjuvant make the capsule of clinical acceptance, tablet,
Granule, pill, oral liquid, emplastrum, ointment, spray, liniment or tincture.
Pharmaceutical composition of the present invention is that pure Chinese medicine is made, and has stronger analgesic activity, and analgesic effect is notable, without relying on
Property, have no side effect.
Experimental example is used for further illustrating the present invention below, but is not limited to the present invention.
Experimental example: pharmacologically active is tested
1, hot plate method
1.1 experimental technique
Water bath topped up with water, makes the water surface contact hot plate, and regulating thermostatic device, water temperature controls at 55 ± 5 DEG C, room temperature 20 ± 1
DEG C hot plate need to preheat 10min.Taking the Kunming mouse 60 of body weight 18~22g, female, each one is merely placed on hot plate, mice
Up to occur licking metapedes or jumping out of the hot plate required time (second) pain threshold as this Mus from being placed on hot plate.All lick foot the time little
In 5 seconds or give it up more than 30 seconds persons.Qualified group is randomly divided into 6 groups of (excipient group, positive controls, Daphne giraldii Nitsche
Plaster group, the embodiment of the present invention 1,2,3 (3 groups), often group 10.Within 24 hours, lose hair or feathers in mouse web portion same area before the test,
Depilation area about 2.0 × 2.0cm2.Basic Pain Threshold value before it is administered is measured after 24h.
Respectively being organized by reagent and be affixed on mouse web portion depilation district respectively, it is 1.0 × 1.0cm that patch powder amasss2, excipient group patch is identical
Area blank is pasted, Zushima gaoyao group, positive controls patch QIZHENG XIAOTONG TIE, the embodiment of the present invention 1 group, the embodiment of the present invention 2
Group, the embodiment of the present invention 3 groups are administered area (120mg kg identical with administration group-1).Fixed with medical proof fabric, outside every day
Patch is administered once, successive administration three days, and 1,2,4,8h after last is administered measure its response time respectively, such as 60 seconds still without anti-
Should, mice is taken out, in order to avoid scalding, its pain threshold calculated with 60 seconds.
1.2 experimental result
With threshold of pain raising percentage rate as vertical coordinate, after administration, different time is that abscissa is mapped to show dose-effect, time-effect relationship.
Simplify random chance method and calculate active drug raising ED in the threshold of pain in a specified time50And 95% credible limit, knot
Close statistical test, respectively organize action intensity.The method of inspection is t-inspection.Specific experiment result is as shown in table 1.
The comparison of hot plate method in mice pain experiments pain threshold respectively organized by table 1
Compare with excipient groupΔP < 0.05,ΔΔP < 0.01
Embodiment of the present invention 1-3 group compares pain threshold with very just disappearing group and Daphne giraldii Nitsche group bitterly, and there were significant differences.
2. acetic acid writhing test
2.1 experimental technique
Take the Kunming mouse 60 of body weight 18~22g, male and female half and half, be randomly divided into 6 groups (blank group, positive controls,
Zushima gaoyao group, each 10 of embodiment of the present invention 1-3 (three groups).Within 24 hours, take off in mouse web portion same area before the test
Hair, lose hair or feathers area about 2.0 × 2.0cm2.Test medicine is respectively organized and is affixed on mouse web portion depilation district respectively, blank patch group patch identical faces
Long-pending blank patch, positive controls patch QIZHENG XIAOTONG TIE, often group is administered area and is respectively 120mg kg-1.Every day, external application was administered one
Secondary, successive administration three days, after last is administered 6h, lumbar injection 0.6% aqueous acetic acid (10mL/kg), then that mice is independent
Put in transparent plastics cage, count its writhing number of times in 20min.
By following equation calculating suppression ratio:
Suppression ratio=(blank group average time-treatment group average time)/blank group average time × 100%.
2.2 experimental result
Each for administration treated animal writhing average is compared with matched group writhing average, carries out statistics t-inspection.Specifically
Experimental result is as shown in table 2:
The compound percutaneous gel of table 2 is on the impact (n=10) of writhing number of times after mouse peritoneal injection acetic acid
Note: compare with blank patch groupΔP < 0.05,ΔΔP < 0.01
Embodiment of the present invention 1-3 group compares analgesia percentage rate with very just disappearing group and Daphne giraldii Nitsche group bitterly, and there were significant differences.
Following embodiment all can realize the effect of above-mentioned experimental example.
Detailed description of the invention
Embodiment 1 emplastrum
Said medicine is added customary adjuvant according to common process and makes emplastrum, 1 day/patch.
Embodiment 2 emplastrum
Said medicine is added customary adjuvant according to common process and makes emplastrum, 1 day/patch.
Embodiment 3 emplastrum
Said medicine is added customary adjuvant according to common process and makes emplastrum, 1 day/patch.
Embodiment 4 capsule
Said medicine adds customary adjuvant according to common process and makes capsule.Within every 6 hours, can take once, each two
Grain.
Embodiment 5 pill
Said medicine adds customary adjuvant according to common process and makes pill.Within every 6 hours, can take once, each 1 ball.
Embodiment 6 tablet
Said medicine is added customary adjuvant according to common process and makes tablet, within every 6 hours, can take once, each 2.
Embodiment 4 ointment
Said medicine adds customary adjuvant according to common process and makes ointment.
Claims (6)
1. a Chinese medicine composition with analgesic activity, it is characterised in that the crude drug of said composition consists of:
2. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
3. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
4. Chinese medicine composition as claimed in claim 1, it is characterised in that the crude drug of said composition consists of:
5. the Chinese medicine composition as described in one of claim 1-4, it is characterised in that said composition often adds according to common process
Emplastrum, ointment, spray, liniment or the tincture of clinical acceptance made by rule adjuvant.
6. the Chinese medicine composition as described in one of claim 1-4 has the application in the medicine of analgesic in preparation treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610522223.3A CN106110243A (en) | 2016-06-28 | 2016-06-28 | A kind of Chinese medicine composition with analgesic activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610522223.3A CN106110243A (en) | 2016-06-28 | 2016-06-28 | A kind of Chinese medicine composition with analgesic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106110243A true CN106110243A (en) | 2016-11-16 |
Family
ID=57468635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610522223.3A Pending CN106110243A (en) | 2016-06-28 | 2016-06-28 | A kind of Chinese medicine composition with analgesic activity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106110243A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1698829A (en) * | 2005-06-15 | 2005-11-23 | 李景辉 | Ointment for trauma and injury and its preparation method |
CN105213901A (en) * | 2015-10-20 | 2016-01-06 | 康明 | A kind of antigout drug compositions, its application and preparation method |
-
2016
- 2016-06-28 CN CN201610522223.3A patent/CN106110243A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1698829A (en) * | 2005-06-15 | 2005-11-23 | 李景辉 | Ointment for trauma and injury and its preparation method |
CN105213901A (en) * | 2015-10-20 | 2016-01-06 | 康明 | A kind of antigout drug compositions, its application and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104666864A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
CN104740425B (en) | A kind of pharmaceutical composition for treating rheumatic Bi syndrome and its production and use | |
CN104491220B (en) | A kind of traditional Chinese medicine composition for herpes | |
CN104288727B (en) | A kind of dedicated compound Chinese medicinal preparation of chill cold in children health care | |
CN103083500A (en) | Chinese medicinal composition treating toxoplasmosis | |
CN103272126A (en) | Traditional Chinese medicine for treating migraine | |
CN101933963B (en) | Nasal in-situ gel for treating headache | |
CN105796654B (en) | Traditional Chinese medicine composition for treating diarrhea-predominant irritable bowel syndrome, navel patch and application | |
CN100569269C (en) | Analgesic | |
CN105168500B (en) | It is a kind of to be used to treat pharmaceutical composition of dental ulcer of infant and preparation method thereof | |
CN101991811B (en) | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof | |
CN105816489A (en) | Preparation method of durio zibethinus murr shell extract and application of durio zibethinus murr shell extract | |
CN109350632A (en) | A kind of Chinese medicine composition for antipyretic-antalgic | |
CN106110243A (en) | A kind of Chinese medicine composition with analgesic activity | |
PT2216039E (en) | Pharmaceutical compositions for treating anxiety | |
CN106377698A (en) | Traditional Chinese medicine composition capable of treating cold | |
CN106265927A (en) | A kind of pharmaceutical composition for treating rhinitis and nasosinusitis and allergic rhinitis | |
CN103083446A (en) | Chinese medicinal composition for prevention of toxoplasmosis | |
CN104147007B (en) | A kind of for analgesic medical composition and its use | |
CN103494900A (en) | Traditional Chinese medicine for treating stiff neck | |
CN102370777A (en) | Medicament for treating non-ulcerated chilblains | |
CN102579730B (en) | Medicine composition for treating acute or chronic cholecystitis and acute or chronic pancreatitis | |
CN102973856B (en) | Anti-cold pharmaceutical composition and preparation method thereof | |
CN100593409C (en) | Medicinal liquor for treating trigeminal neuralgia | |
CN105456284B (en) | A kind of drug for treating cough |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |